Risk factors for drug-treated major adverse cardio-cerebrovascular events in patients on primary preventive statin therapy: A retrospective cohort study

We aim to identify risk factors of major adverse cardio-cerebrovascular events (MACCE) using a proxy of drug treatment for a MACCE after the start of statin therapy in the primary cardiovascular prevention group, taking drug dose, persistency and adherence into account. We conducted a retrospective...

Full description

Bibliographic Details

Published in:	Preventive Medicine Reports
Main Authors:	Dennis Steenhuis, Stijn de Vos, Jens H.J. Bos, Eelko Hak
Format:	Article
Language:	English
Published:	Elsevier 2023-08-01
Subjects:	Statin therapy HMG-CoA reductase inhibitors Primary prevention Cardio-cerebrovascular events Pharmacoepidemiology Risk factors
Online Access:	http://www.sciencedirect.com/science/article/pii/S2211335523001493